These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 32459710)
21. Co-occurrence of autism, childhood psychosis, and intellectual disability associated with a de novo 3q29 microdeletion. Sagar A; Bishop JR; Tessman DC; Guter S; Martin CL; Cook EH Am J Med Genet A; 2013 Apr; 161A(4):845-9. PubMed ID: 23443968 [TBL] [Abstract][Full Text] [Related]
22. 1.3 Mb de novo deletion in chromosome band 3q29 associated with normal intelligence in a child. Cobb W; Anderson A; Turner C; Hoffman RD; Schonberg S; Levin SW Eur J Med Genet; 2010; 53(6):415-8. PubMed ID: 20832509 [TBL] [Abstract][Full Text] [Related]
23. EEG findings in a pediatric patient with 3q29 microdeletion syndrome. Sheikh IS; Nascimento FA; Waite SR; Lam AD Epileptic Disord; 2024 Feb; 26(1):151-153. PubMed ID: 37767975 [No Abstract] [Full Text] [Related]
24. 3q29 microdeletion syndrome associated with developmental delay and pulmonary stenosis: a case report. Kaba D; Çelik ZY Turk J Pediatr; 2022; 64(5):925-931. PubMed ID: 36305444 [TBL] [Abstract][Full Text] [Related]
25. Familial 3q29 microdeletion syndrome providing further evidence of involvement of the 3q29 region in bipolar disorder. Clayton-Smith J; Giblin C; Smith RA; Dunn C; Willatt L Clin Dysmorphol; 2010 Jul; 19(3):128-132. PubMed ID: 20453639 [TBL] [Abstract][Full Text] [Related]
26. Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: A case series. Malt EA; Juhasz K; Frengen A; Wangensteen T; Emilsen NM; Hansen B; Agafonov O; Nilsen HL Mol Genet Genomic Med; 2019 Sep; 7(9):e889. PubMed ID: 31347308 [TBL] [Abstract][Full Text] [Related]
28. Gait disturbance in a patient with de novo 1.0-kb SOX2 microdeletion. Yamada H; Okanishi T; Okazaki T; Oguri M; Fukuda H; Uchiyama Y; Mizuguchi T; Matsumoto N; Maegaki Y Brain Dev; 2022 Jan; 44(1):68-72. PubMed ID: 34332824 [TBL] [Abstract][Full Text] [Related]
29. Dystonia in a patient with deletion of 18p. Tezzon F; Zanoni T; Passarin MG; Ferrari G Ital J Neurol Sci; 1998 Apr; 19(2):90-3. PubMed ID: 10935843 [TBL] [Abstract][Full Text] [Related]
30. Refining critical regions in 15q24 microdeletion syndrome pertaining to autism. Liu Y; Zhang Y; Zarrei M; Dong R; Yang X; Zhao D; Scherer SW; Gai Z Am J Med Genet B Neuropsychiatr Genet; 2020 Jun; 183(4):217-226. PubMed ID: 31953991 [TBL] [Abstract][Full Text] [Related]
31. NCBP2 modulates neurodevelopmental defects of the 3q29 deletion in Drosophila and Xenopus laevis models. Singh MD; Jensen M; Lasser M; Huber E; Yusuff T; Pizzo L; Lifschutz B; Desai I; Kubina A; Yennawar S; Kim S; Iyer J; Rincon-Limas DE; Lowery LA; Girirajan S PLoS Genet; 2020 Feb; 16(2):e1008590. PubMed ID: 32053595 [TBL] [Abstract][Full Text] [Related]
33. A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8. Yasin H; Gibson WT; Langlois S; Stowe RM; Tsang ES; Lee L; Poon J; Tran G; Tyson C; Wong CK; Marra MA; Friedman JM; Zahir FR J Hum Genet; 2019 Apr; 64(4):271-280. PubMed ID: 30670789 [TBL] [Abstract][Full Text] [Related]
34. Microdeletion 8q22.2-q22.3 in a 40-year-old male. Sinajon P; Gofine T; Ingram J; So J Eur J Med Genet; 2015 Nov; 58(11):569-72. PubMed ID: 26455667 [TBL] [Abstract][Full Text] [Related]
35. 15q24.1 BP4-BP1 microdeletion unmasking paternally inherited functional polymorphisms combined with distal 15q24.2q24.3 duplication in a patient with epilepsy, psychomotor delay, overweight, ventricular arrhythmia. Huynh MT; Lambert AS; Tosca L; Petit F; Philippe C; Parisot F; Benoît V; Linglart A; Brisset S; Tran CT; Tachdjian G; Receveur A Eur J Med Genet; 2018 Aug; 61(8):459-464. PubMed ID: 29549028 [TBL] [Abstract][Full Text] [Related]
36. Treatment-resistant psychotic symptoms and early-onset dementia: A case report of the 3q29 deletion syndrome. Harner MK; Lichtenstein M; Farrell M; Dietterich TE; Filmyer DM; Bruno LM; Biondi TF; Crowley JJ; Lázaro-Muñoz G; Stowe R; Shaughnessy RA; Berg JS; Szatkiewicz J; Sullivan PF; Josiassen RC Schizophr Res; 2020 Oct; 224():195-197. PubMed ID: 32943312 [TBL] [Abstract][Full Text] [Related]
37. Behavioral changes and growth deficits in a CRISPR engineered mouse model of the schizophrenia-associated 3q29 deletion. Rutkowski TP; Purcell RH; Pollak RM; Grewenow SM; Gafford GM; Malone T; Khan UA; Schroeder JP; Epstein MP; Bassell GJ; Warren ST; Weinshenker D; Caspary T; Mulle JG Mol Psychiatry; 2021 Mar; 26(3):772-783. PubMed ID: 30976085 [TBL] [Abstract][Full Text] [Related]
38. The 3q29 deletion confers >40-fold increase in risk for schizophrenia. Mulle JG Mol Psychiatry; 2015 Sep; 20(9):1028-9. PubMed ID: 26055425 [No Abstract] [Full Text] [Related]
39. Association of structural and numerical anomalies of chromosome 22 in a patient with syndromic intellectual disability. Naoufal R; Legendre M; Couet D; Gilbert-Dussardier B; Kitzis A; Bilan F; Harbuz R Eur J Med Genet; 2016 Sep; 59(9):483-7. PubMed ID: 27452446 [TBL] [Abstract][Full Text] [Related]
40. 19q13.32 microdeletion syndrome: three new cases. Castillo A; Kramer N; Schwartz CE; Miles JH; DuPont BR; Rosenfeld JA; Graham JM Eur J Med Genet; 2014; 57(11-12):654-8. PubMed ID: 25230004 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]